Weisen Wins CES Innovation Award for 3 Consecutive Years... Respiratory Screening & Allergy DTx

AI MedTech specialist company Waisen has won three CES Innovation Awards ahead of CES 2024, the world's largest electronics and IT exhibition, held in Las Vegas, USA, in January next year.

[Photo by Weisen]

According to the CES 2024 Innovation Award results announced on the 16th by the Consumer Technology Association (CTA), which organizes CES, Waisen received three Innovation Awards for WAYMED Cough PRO and WAYMED Food Allergy. Two awards were in the AI category, and one was in the Software and Mobile Applications category.

The two awarded products were both AI-based and developed through joint research with specialized medical professionals in each field. It is explained that medical experts and AI specialist companies collaborated to develop clinically useful products with technical validation.

WAYMED Cough PRO is an AI self-screening app service that can check the user's respiratory health condition with only about 3 to 5 cough sounds. It was developed through joint research with the research team of Professor Moon Kyung-min from the Department of Respiratory Allergy at Chung-Ang University Hospital and Director Jeon Jin-hee (former Yonsei BNA Clinic). Based on AI, it analyzes the user's respiratory health and helps people of all ages easily manage their respiratory health. It also connects the input respiratory data with medical institutions to expand into remote medical services, which was recognized for its innovation. Following the CES 2023 Innovation Award received last January, it earned the honor of winning the Innovation Award for two consecutive years.

WAYMED Food Allergy, which won two Innovation Awards this time, is an AI-based customized oral immunotherapy digital therapeutic device (DTx) for children and adolescents with food allergies. It is a result of joint research with the research team of Professors Ahn Gang-mo and Kim Ji-hyun from the Pediatric Allergy and Respiratory Department at Samsung Seoul Hospital, utilizing Waisen's medical big data analysis technology and AI algorithms. It predicts the degree of allergic reactions based on pediatric patients' blood test information and helps safely and conveniently conduct oral immunotherapy at home through digital technology and interactive communication using big data analysis. This innovation was recognized in both the AI category and the Software and Mobile App category, earning two awards.

Based on its technological capabilities, Waisen has received a total of eight CES Innovation Awards over three consecutive years in just four years since its establishment. The company stated, "While the previous CES Innovation Awards recognized the innovation and technological capabilities of our real-time video analysis technology, this time’s awards acknowledge the technological excellence and innovation of Waisen’s new digital healthcare product lineup on a global scale."

This content was produced with the assistance of AI translation services.